TSC2 c.1625C>G ;(p.P542R)

Variant ID: 16-2115545-C-G

NM_000548.3(TSC2):c.1625C>G;(p.P542R)

This variant was identified in 1 publication

View GRCh38 version.




Publications:


Personalized First-Line Treatment of Metastatic Pancreatic Neuroendocrine Carcinoma Facilitated by Liquid Biopsy and Computational Decision Support.

Diagnostics (Basel, Switzerland)
Szkukalek, Judita J; Dóczi, Róbert R; Dirner, Anna A; Boldizsár, Ákos Á; Varga, Ágnes Á; Déri, Júlia J; Lakatos, Dóra D; Tihanyi, Dóra D; Vodicska, Barbara B; Schwáb, Richárd R; Pajkos, Gábor G; Várkondi, Edit E; Vályi-Nagy, István I; Valtinyi, Dorottya D; Nagy, Zsuzsanna Z; Peták, István I
Publication Date: 2021-10-07

Variant appearance in text: TSC2: P542R
PubMed Link: 34679548
Variant Present in the following documents:
  • Main text
  • diagnostics-11-01850.pdf
View BVdb publication page